|
| 37589538 | Improving <i>SUVR</i> quantification by correcting for radiotracer clearance in tissue. | J Cereb Blood Flow Metab | 2024 |
| 38013422 | Evaluation of a First PET Tracer Suitable for Imaging the Sigma-2 Receptor in the Brain of Nonhuman Primates. | Mol Pharm | 2024 |
| 36048541 | DuDoSS: Deep-learning-based dual-domain sinogram synthesis from sparsely sampled projections of cardiac SPECT. | Med Phys | 2023 |
| 37669455 | Evaluating infusion methods and simplified quantification of synaptic density <i>in vivo</i> with [<sup>11</sup>C]UCB-J and [<sup>18</sup>F]SynVesT-1 PET. | J Cereb Blood Flow Metab | 2023 |
| 37997577 | Generation of Whole-Body FDG Parametric <i>K</i><sub>i</sub> Images from Static PET Images Using Deep Learning. | IEEE Trans Radiat Plasma Med Sci | 2023 |
| 37259346 | In Vivo Imaging and Kinetic Modeling of Novel Glycogen Synthase Kinase-3 Radiotracers [<sup>11</sup>C]OCM-44 and [<sup>18</sup>F]OCM-50 in Non-Human Primates. | Pharmaceuticals (Basel) | 2023 |
| 37422964 | Principal component analysis of synaptic density measured with [<sup>11</sup>C]UCB-J PET in early Alzheimer's disease. | Neuroimage Clin | 2023 |
| 37382240 | Relationships of in vivo brain norepinephrine transporter and age, BMI, and gender. | Synapse | 2023 |
| 36849748 | Preclinical evaluation of a brain penetrant PARP PET imaging probe in rat glioblastoma and nonhuman primates. | Eur J Nucl Med Mol Imaging | 2023 |
| 36515395 | Neurotransmitter transporter occupancy following administration of centanafadine sustained-release tablets: A phase 1 study in healthy male adults. | J Psychopharmacol | 2023 |
| 36846134 | Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [<sup>18</sup>F]SDM-16. | Front Neurol | 2023 |
| 36640190 | Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetine. | Psychopharmacology (Berl) | 2023 |
| 36507985 | Noninvasive Quantitative PET Imaging in Humans of the Pancreatic Beta-Cell Mass Biomarkers VMAT2 and Dopamine D2/D3 Receptors In Vivo. | Methods Mol Biol | 2023 |
| 36908710 | Linking resting-state network fluctuations with systems of coherent synaptic density: A multimodal fMRI and <sup>11</sup>C-UCB-J PET study. | Front Hum Neurosci | 2023 |
| 36825693 | Investigating CNS distribution of PF-05212377, a P-glycoprotein substrate, by translation of 5-HT<sub>6</sub> receptor occupancy from non-human primates to humans. | Biopharm Drug Dispos | 2023 |
| 36104858 | A 3D atlas of functional human brain energetic connectome based on neuropil distribution. | Cereb Cortex | 2023 |
| 32415628 | Feasibility study of PET dynamic imaging of [[18]F]DHMT for quantification of reactive oxygen species in the myocardium of large animals. | J Nucl Cardiol | 2022 |
| 35710735 | Evaluation of (<i>rac</i>)-, (<i>R</i>)-, and (<i>S</i>)-<sup>18</sup>F-OF-NB1 for Imaging GluN2B Subunit-Containing <i>N</i>-Methyl-d-Aspartate Receptors in Nonhuman Primates. | J Nucl Med | 2022 |
| 35649655 | Imaging of Synaptic Density in Neurodegenerative Disorders. | J Nucl Med | 2022 |
| 35648810 | Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q. | Sci Transl Med | 2022 |
| 35345546 | PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging. | Front Neurosci | 2022 |
| 35503134 | Feasibility of imaging synaptic density in the human spinal cord using [<sup>11</sup>C]UCB-J PET. | EJNMMI Phys | 2022 |
| 35633376 | Imaging the fetal nonhuman primate brain with SV2A positron emission tomography (PET). | Eur J Nucl Med Mol Imaging | 2022 |
| 36243269 | Age, gender and body-mass-index relationships with in vivo CB<sub>1</sub> receptor availability in healthy humans measured with [<sup>11</sup>C]OMAR PET. | Neuroimage | 2022 |
| 36261057 | An objective evaluation method for head motion estimation in PET-Motion corrected centroid-of-distribution. | Neuroimage | 2022 |
| 35948562 | Local molecular and global connectomic contributions to cross-disorder cortical abnormalities. | Nat Commun | 2022 |
| 36346513 | Drug characteristics derived from kinetic modeling: combined <sup>11</sup>C-UCB-J human PET imaging with levetiracetam and brivaracetam occupancy of SV2A. | EJNMMI Res | 2022 |
| 36185820 | Optimized Methodology for Reference Region and Image-Derived Input Function Kinetic Modeling in Preclinical PET. | IEEE Trans Radiat Plasma Med Sci | 2022 |
| 35257856 | Adaptive data-driven motion detection and optimized correction for brain PET. | Neuroimage | 2022 |
| 34852401 | Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory <sup>11</sup> C-UCB-J positron emission tomography study in humans. | Addict Biol | 2022 |
| 35244788 | Target occupancy study and whole-body dosimetry with a MAGL PET ligand [<sup>11</sup>C]PF-06809247 in non-human primates. | EJNMMI Res | 2022 |
| 35209743 | Comparison of three novel radiotracers for GluN2B-containing NMDA receptors in non-human primates: (R)-[[11]C]NR2B-Me, (R)-[[18]F]of-Me-NB1, and (S)-[[18]F]of-NB1. | J Cereb Blood Flow Metab | 2022 |
| 35174954 | Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [<sup>11</sup> C]UCB-J. | Alzheimers Dement | 2022 |
| 35236846 | PET-BIDS, an extension to the brain imaging data structure for positron emission tomography. | Sci Data | 2022 |
| 35107627 | Characterization in nonhuman primates of (R)-[<sup>18</sup>F]OF-Me-NB1 and (S)-[<sup>18</sup>F]OF-Me-NB1 for imaging the GluN2B subunits of the NMDA receptor. | Eur J Nucl Med Mol Imaging | 2022 |
| 35020138 | Translational PET Imaging of Spinal Cord Injury with the Serotonin Transporter Tracer [<sup>11</sup>C]AFM. | Mol Imaging Biol | 2022 |
| 34761284 | A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [<sup>18</sup>F]SDM-16. | Eur J Nucl Med Mol Imaging | 2022 |
| 34609758 | Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [<sup>11</sup> C]PBR28 and Machine Learning Analysis. | Mov Disord | 2022 |
| 34385336 | Imaging Pituitary Vasopressin 1B Receptor in Humans with the PET Radiotracer <sup>11</sup>C-TASP699. | J Nucl Med | 2022 |
| 32757741 | Binding of the synaptic vesicle radiotracer [<sup>11</sup>C]UCB-J is unchanged during functional brain activation using a visual stimulation task. | J Cereb Blood Flow Metab | 2021 |
| 33757318 | Comparison of [<sup>11</sup>C]UCB-J and [<sup>18</sup>F]FDG PET in Alzheimer's disease: A tracer kinetic modeling study. | J Cereb Blood Flow Metab | 2021 |
| 34839360 | Data-driven analysis of kappa opioid receptor binding in major depressive disorder measured by positron emission tomography. | Transl Psychiatry | 2021 |
| 34569803 | Novel Reversible-Binding PET Ligands for Imaging Monoacylglycerol Lipase Based on the Piperazinyl Azetidine Scaffold. | J Med Chem | 2021 |
| 34651587 | Imaging brain cortisol regulation in PTSD with a target for 11β-hydroxysteroid dehydrogenase type 1. | J Clin Invest | 2021 |
| 34224153 | Generation of synthetic PET images of synaptic density and amyloid from <sup>18</sup> F-FDG images using deep learning. | Med Phys | 2021 |
| 34119639 | Partial volume correction analysis for <sup>11</sup>C-UCB-J PET studies of Alzheimer's disease. | Neuroimage | 2021 |
| 34287939 | Generation of parametric K<sub>i</sub> images for FDG PET using two 5-min scans. | Med Phys | 2021 |
| 34052464 | Effect of age on brain metabotropic glutamate receptor subtype 5 measured with [[18]F]FPEB PET. | Neuroimage | 2021 |
| 34050746 | Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy. | Clin Infect Dis | 2021 |
| 34000404 | Identifying brain networks in synaptic density PET (<sup>11</sup>C-UCB-J) with independent component analysis. | Neuroimage | 2021 |